A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

J&J will now pick up almost the full tab for the phase 3 trial, and in return Nanobiotix will see the potential milestone payments that could come its way drop $105 million to $2.6 billion. Shares in ...

I knew I was kind of a guinea pig, but the only other option was staying at home, and I wasn’t going to make it,” Tim Story ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Scientists from the University of Auckland have discovered that a cancer drug called alpelisib may help extend lifespan—at ...

We need to keep supporting this kind of research,” a Connecticut researcher and doctor said. “To see if we replicate these ...

When experienced researcher Renato Aguilera happened across the chemical structure of a tried-and-true antimalarial drug one ...

Six months after publicly revealing his “incurable” cancer diagnosis to the nation, Nigel Latta has said he’s responded well ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...